GENESYS:NSE:NSE-Genesys International Corporation Limited (INR)

COMMON STOCK | Software - Application |

Last Closing

USD 514.05

Change

0.00 (0.00)%

Market Cap

USD 19.78B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Software - Application

Symbol Name Price(Change) Market Cap
TATAELXSI:NSE Tata Elxsi Limited

-144.65 (-1.99%)

USD 443.61B
INTELLECT:NSE Intellect Design Arena Limited

+9.45 (+0.89%)

USD 143.30B
NEWGEN:NSE Newgen Software Technologies L..

+12.35 (+1.23%)

USD 140.46B
TANLA:NSE Tanla Platforms Limited

-0.20 (-0.02%)

USD 126.59B
KFINTECH:NSE Kfin Technologies Limited

-3.35 (-0.49%)

USD 122.58B
RATEGAIN:NSE Rategain Travel Technologies L..

-6.55 (-0.87%)

USD 92.95B
EMUDHRA:NSE eMudhra Limited

+33.05 (+3.86%)

USD 70.93B
BBOX:NSE Black Box Limited

+29.03 (+11.14%)

USD 47.68B
NUCLEUS:NSE Nucleus Software Exports Limit..

+6.75 (+0.47%)

USD 36.03B
QUICKHEAL:NSE Quick Heal Technologies Limite..

-9.50 (-1.80%)

USD 28.47B

ETFs Containing GENESYS:NSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Software - Application) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.34% 74% C 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.34% 74% C 64% D
Trailing 12 Months  
Capital Gain 59.40% 52% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.40% 52% F 63% D
Trailing 5 Years  
Capital Gain 461.50% 67% D+ 81% B-
Dividend Return 0.14% 14% F 1% F
Total Return 461.63% 67% D+ 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 133.52% 89% A- 96% N/A
Dividend Return 133.53% 89% A- 96% N/A
Total Return 0.01% 9% A- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 185.24% 11% F 4% F
Risk Adjusted Return 72.08% 59% D- 60% D-
Market Capitalization 19.78B 63% D 50% F

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector